PROCTER & Gamble has announced an agreement to buy the consumer health business of Merck for 3.4 billion.
The deal includes more than 900 products which are sold in 44 countries, including Neruobion, Femibon, Nasivin and many more.
The above article was sent to subscribers in Pharmacy Daily's issue from 20 Apr 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 20 Apr 18
